R. Szydłowski, “PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk”, Qual Sport, vol. 36, p. 56299, Dec. 2024.